About this trial
Background Newborns perceive the world through sound, and music therapy in the neonatal intensive care unit has been shown to have significant benefits in terms of heart rate, oxygen saturation, sucking/feeding capacity, and length of hospital stay. However, it is still unclear what kind of music therapy can better promote early extrauterine growth in preterm infants, and further exploration and practice are needed. Music therapy is an emerging interdisciplinary discipline that integrates musicology, medicine, and psychology. In the uterine environment, the most important rhythmic sounds that the fetus can hear is the mother's heartbeat, as well as the fetus's own heartbeat. The maternal heart rate ranges from 60 to 100 beats/min, and the corresponding speed of 60-100 beats/min in music is medium speed. The fetal heart rate is 110-160 beats/min, and the corresponding speed of 110-160 beats/min in music is considered fast. Music slower than 40-50 beats/min is slow. The primary objective of this study is to investigate the effect of music therapy at different music speeds in preterm infants, at the time to full enteral feeding.
Methods This is a single-center, randomized, open-label, parallel-controlled trial including 284 preterm newborns with gestational age or corrected gestational age ≥32 weeks admitted into the neonatal intensive care unit. The infants will be randomly allocated to receive music I, II, III or control therapy. The music therapy is provided with the same music in three different tempos: 40-50 beats/min, 60-100 beats/min, and 110-160 beats/min, by two professional licensed music therapists using the same instrument and singing, before morning and afternoon feeding time every day during hospitalization. The primary outcome is the time to achieving full enteral feeding. The secondary outcomes include sucking/feeding capacity, physical growth rate, complications, length of hospital stay, behavior state (Test of Infant Motor Performance (TIMP), Bayley III Infant Development Scale), and brain imaging (resting functional magnetic resonance imaging).
Hypothesis:
The investigator expect that either music therapy applied at 40-50 beats/min or 110-160 beats/min will result in early full enteral feeding, and reductions in length of hospital stay and complications in preterm infants.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Preterm infants of gestational age ≥32 weeks or corrected gestational age ≥32 weeks
Admitted to hospital within 24 hours after birth
Apgar score ≥8 points
Normal auditory function according to examination of brainstem auditory evoked potential
Disqualifiers
Congenital system defects including congenital heart disease, nervous system malformations, diaphragmatic hernias, gastrointestinal malformations
Serious complications, such as intracranial hemorrhage, respiratory failure, or serious infection, and those requiring mechanical ventilation
Trial design
Parallel
Treatments tested in this trial
Music Therapy
BehavioralThe intervention will be conducted while the infants are hospitalized, 30 minutes before morning and afternoon feeds. The intervention sessions will last for 20 minutes per session. During the treatment, the same therapist, in the same order, and with the same instrument, will in turn play the four repertoires to each of the three intervention groups.
Treatment groups
Trial outcomes
Primary outcomes
Whole enteral feeding age
Whole enteral feeding age will be measured as age at full enteral feeding, which is 150 ml/(kg·d) enteral feeding.
Secondary outcomes
Physical growth rate
Physical growth rate will be measured through head circumference and weight growth rate per week.
Gastrointestinal condition: 1. Daily feeding amount
Gastrointestinal conditions will be measured through daily feeding amount.
Gastrointestinal condition: 2. Gastrointestinal function indicators
Gastrointestinal conditions will be measured through gastrointestinal function indicators: gastrin-17, pepsinogen I and pepsinogen II.
Gastrointestinal condition: 3. Calcium and phosphorus metabolism
Gastrointestinal conditions will be measured through nutritional indicators: calcium and phosphorus, alkaline phosphatase.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead sponsor
Shanghai Conservatory of Music
Collaborator
This trial is not recruiting at the moment. You can still explore other options: